4/18
08:29 am
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $85.00 to $82.00. They now have a "buy" rating on the stock.
Medium
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $85.00 to $82.00. They now have a "buy" rating on the stock.
4/10
07:00 am
tech
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
Medium
Report
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
4/8
07:18 am
tech
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY [Yahoo! Finance]
Low
Report
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY [Yahoo! Finance]
4/8
07:00 am
tech
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Low
Report
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
4/4
09:04 am
tech
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence [Seeking Alpha]
Neutral
Report
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence [Seeking Alpha]
4/3
07:09 am
tech
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE [Yahoo! Finance]
Low
Report
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE [Yahoo! Finance]
4/3
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
Low
Report
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
4/2
11:56 am
tech
Global Recombinant Proteins Market Report - Growth Factors & Chemokines Segment to Dominate Market During Forecast Period 2024-2028 [Yahoo! Finance]
Low
Report
Global Recombinant Proteins Market Report - Growth Factors & Chemokines Segment to Dominate Market During Forecast Period 2024-2028 [Yahoo! Finance]
4/1
07:06 am
tech
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS [Yahoo! Finance]
Low
Report
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS [Yahoo! Finance]
4/1
07:00 am
tech
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
Medium
Report
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
4/1
06:58 am
tech
Bio-Techne (NASDAQ:TECH) shareholders have earned a 7.4% CAGR over the last five years [Yahoo! Finance]
Medium
Report
Bio-Techne (NASDAQ:TECH) shareholders have earned a 7.4% CAGR over the last five years [Yahoo! Finance]
3/28
10:09 am
tech
Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services [Yahoo! Finance]
Neutral
Report
Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services [Yahoo! Finance]
3/28
09:16 am
tech
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES [Yahoo! Finance]
Low
Report
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES [Yahoo! Finance]
3/28
09:00 am
tech
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
Low
Report
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
3/25
01:48 pm
tech
GSK or TECH: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Low
Report
GSK or TECH: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
3/22
07:10 am
tech
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA [Yahoo! Finance]
Low
Report
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA [Yahoo! Finance]
3/22
07:00 am
tech
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Low
Report
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
3/13
02:18 pm
tech
Bio-Techne and Qiagen had the biggest increase in short interest levels last month - Baird [Seeking Alpha]
Low
Report
Bio-Techne and Qiagen had the biggest increase in short interest levels last month - Baird [Seeking Alpha]
3/12
07:17 am
tech
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM [Yahoo! Finance]
Low
Report
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM [Yahoo! Finance]
3/12
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
Low
Report
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
3/7
09:16 am
tech
Tom O'Lenic joins RedShiftBio as Chief Executive Officer [Yahoo! Finance]
Low
Report
Tom O'Lenic joins RedShiftBio as Chief Executive Officer [Yahoo! Finance]
3/6
07:12 am
tech
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE [Yahoo! Finance]
Low
Report
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE [Yahoo! Finance]
3/6
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
Low
Report
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
3/2
09:00 am
tech
What Does Bio-Techne Corporation's (NASDAQ:TECH) Share Price Indicate? [Yahoo! Finance]
Low
Report
What Does Bio-Techne Corporation's (NASDAQ:TECH) Share Price Indicate? [Yahoo! Finance]
2/23
06:25 am
tech
What Makes Bio-Techne Corporation (TECH) an Investment Bet? [Yahoo! Finance]
Low
Report
What Makes Bio-Techne Corporation (TECH) an Investment Bet? [Yahoo! Finance]